Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28163257 | 0.87 | CA1 (0.60) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL7824851 | 0.83 | CA1 (0.41) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL13226853 | 0.83 | CA1 (0.41) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL6865202 | 0.81 | TAS2R14 (0.35) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL12522205 | 0.81 | CA1 (0.40) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL3348943 | 0.79 | CA1 (0.67) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL27373743 | 0.78 | CNR2 (0.45) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL381097 | 0.77 | CA1 (0.56) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL43599 | 0.76 | SMN1; SMN2 (0.36) | CA1CA12CA2CA14SMN1; SMN2 | |
| SCHEMBL2880721 | 0.76 | CA1 (0.38) | CA1CA12CA2CA14SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103911615-B | Etching agent composite for copper-containing metal | 东友精细化工有限公司 | 2017-08-22 | — | — | CN | claimed |
| EP-2238138-A1 | TRICYCLIC NITROGEN COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | Glaxo Group Limited (GB) | 2010-10-13 | — | — | EP | claimed |
| WO-2009087153-A1 | TRICYCLIC NITROGEN COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2009-07-16 | — | — | WO | claimed |
| EP-0074894-B1 | PROCESS FOR THE PURIFICATION OF A GASEOUS MIXTURE CONTAINING UNDESIRABLE GASEOUS COMPOUNDS | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1985-01-02 | — | — | EP | claimed |
| EP-0074894-A1 | Process for the purification of a gaseous mixture containing undesirable gaseous compounds | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1983-03-23 | — | — | EP | claimed |
| US-4170547-A | SOLVENT EXTRACTION | COMPAGNIE FRANCAISE DE RAFFINAGE (FR) | 1979-10-09 | — | — | US | claimed |
| CN-122051425-A | Water system lithium metal battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | disclosed |
| EP-2343298-B9 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | INCYTE HOLDINGS CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| CN-103911615-B | Etching agent composite for copper-containing metal | 东友精细化工有限公司 | 2017-08-22 | — | — | CN | disclosed |
| EP-2376447-B1 | DIPEPTIDYL PEPTIDASE IV INHIBITORS | ORCHID PHARMA LTD (IN) | 2017-08-09 | — | — | EP | disclosed |
| WO-2015095701-A1 | SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME | THE INSTITUTE FOR DRUG DELIVERY (US) | 2015-06-25 | — | — | WO | disclosed |
| US-9065146-B2 | Nonaqueous electrolyte and lithium secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2348023-B1 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | INCYTE CORP (US) | 2015-05-06 | — | — | EP | disclosed |
| WO-2005026151-A1 | QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2005026152-A1 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2005-03-24 | — | — | WO | disclosed |
| EP-1487806-A1 | 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | Astrazeneca AB (SE) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003082831-A1 | 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | ASTRAZENECA AB (SE) | 2003-10-09 | — | — | WO | disclosed |
| EP-0074894-B1 | PROCESS FOR THE PURIFICATION OF A GASEOUS MIXTURE CONTAINING UNDESIRABLE GASEOUS COMPOUNDS | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1985-01-02 | — | — | EP | disclosed |
| EP-0074894-A1 | Process for the purification of a gaseous mixture containing undesirable gaseous compounds | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1983-03-23 | — | — | EP | disclosed |
| US-4170547-A | SOLVENT EXTRACTION | COMPAGNIE FRANCAISE DE RAFFINAGE (FR) | 1979-10-09 | — | — | US | disclosed |